FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19486311000001101: Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Sep 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1577891000001112 Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1577901000001113 Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Is a Regadenoson 400micrograms/5ml solution for injection vials true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has active ingredient Regadenoson true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has specific active ingredient Regadenoson true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Is a Rapiscan true Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has manufactured dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) 1 vial Has AMP True Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start